Ja H. Koo

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Paulobutalipin, a Lipid Accumulation Inhibitor from a Streptomyces sp.

Paulobutalipin, a Lipid Accumulation Inhibitor from a Streptomyces sp.

Journal: Journal of natural products

Published: January 26, 2026

ASB3 degrades the gateway to β-oxidation: Editorial on "Hepatocytic ankyrin repeat and SOCS box protein 3 deficiency alleviates metabolic dysfunction-associated steatotic liver disease by decreasing ubiquitin-mediated carnitine palmitoyl transferase 1A".

ASB3 degrades the gateway to β-oxidation: Editorial on "Hepatocytic ankyrin repeat and SOCS box protein 3 deficiency alleviates metabolic dysfunction-associated steatotic liver disease by decreasing ubiquitin-mediated carnitine palmitoyl transferase 1A".

Journal: Clinical and molecular hepatology

Published: September 09, 2025

In Vivo Monitoring of Hepatic Ischemia Using a Dual-Enzyme Activated Near-Infrared Fluorescence Probe.

In Vivo Monitoring of Hepatic Ischemia Using a Dual-Enzyme Activated Near-Infrared Fluorescence Probe.

Journal: ACS sensors

Published: August 11, 2025

Triggering Mechanisms of Hepatocyte Repopulation during Liver Regeneration.

Triggering Mechanisms of Hepatocyte Repopulation during Liver Regeneration.

Journal: Biomolecules & therapeutics

Published: March 04, 2025

Liver Stiffness Directs Intrahepatic Cholesterol Accumulation Through YAP/TAZ in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Liver Stiffness Directs Intrahepatic Cholesterol Accumulation Through YAP/TAZ in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 07, 2025

Stabilizing hepatic fatty acid oxidation: Editorial on "USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination".

Stabilizing hepatic fatty acid oxidation: Editorial on "USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination".

Journal: Clinical and molecular hepatology

Published: October 31, 2024

Longitudinal evaluation of liver stiffness reveals hepatic cholesterol as the determinant of fibrosis progression in mice.

Longitudinal evaluation of liver stiffness reveals hepatic cholesterol as the determinant of fibrosis progression in mice.

Journal: Life sciences

Published: July 24, 2024

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression.

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression.

Journal: Archives of pharmacal research

Published: April 08, 2024

Mitochondrial stress activates YAP/TAZ through RhoA oxidation to promote liver injury.

Mitochondrial stress activates YAP/TAZ through RhoA oxidation to promote liver injury.

Journal: Cell death & disease

Published: October 13, 2023

Endoplasmic Reticulum Stress Activates Hepatic Macrophages through PERK-hnRNPA1 Signaling.

Endoplasmic Reticulum Stress Activates Hepatic Macrophages through PERK-hnRNPA1 Signaling.

Journal: Biomolecules & therapeutics

Published: October 04, 2023

Identification of the primary ciliary proteins IFT38 and IFT144 to enhance serum-mediated YAP activation and cell proliferation.

Identification of the primary ciliary proteins IFT38 and IFT144 to enhance serum-mediated YAP activation and cell proliferation.

Journal: Biochemical and biophysical research communications

Published: September 13, 2023

Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation.

Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation.

Journal: Cell communication and signaling : CCS

Published: August 02, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026